Literature DB >> 17019790

Methamphetamine and HIV.

Bob Huff.   

Abstract

When the New York City Department of Health and Mental Hygiene announced in January 2005 that a gay man in his forties had become infected with a multidrug-resistant "superstrain" of HIV and had progressed to AIDS within a few months, much was made of the man's use of methamphetamine. The case highlighted two important aspects of the intersection of methamphetamine use and HIV. First is the fairly well-established role the drug can play in facilitating new infections by lowering users' inhibitions and encouraging sexual practices that increase the risk of HIV transmission. The second aspect is the idea that methamphetamine somehow speeds up the HIV disease process. There is little evidence of a direct interaction between meth and HIV that accelerates immune decline, but meth use can undermine the general health of the user. There is also a growing body of evidence that meth's harmful effects on the brain may be exacerbated in people with HIV, and that many HIV-related neurological impairments may be worsened by meth use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17019790

Source DB:  PubMed          Journal:  BETA        ISSN: 1058-708X


  4 in total

1.  Behavioral regulation in methamphetamine abusers: an fMRI study.

Authors:  Ruth Salo; Catherine Fassbender; Michael H Buonocore; Stefan Ursu
Journal:  Psychiatry Res       Date:  2012-11-10       Impact factor: 3.222

2.  Changes in the plasma proteome follows chronic opiate administration in simian immunodeficiency virus infected rhesus macaques.

Authors:  Jayme L Wiederin; Fang Yu; Robert M Donahoe; Howard S Fox; Pawel Ciborowski; Howard E Gendelman
Journal:  Drug Alcohol Depend       Date:  2011-08-06       Impact factor: 4.492

Review 3.  HIV, Tat and dopamine transmission.

Authors:  Peter J Gaskill; Douglas R Miller; Joyonna Gamble-George; Hideaki Yano; Habibeh Khoshbouei
Journal:  Neurobiol Dis       Date:  2017-04-27       Impact factor: 5.996

4.  Multifunctional Nanotherapeutics for the Treatment of neuroAIDS in Drug Abusers.

Authors:  Rahul Dev Jayant; Sneham Tiwari; Venkata Atluri; Ajeet Kaushik; Asahi Tomitaka; Adriana Yndart; Luis Colon-Perez; Marcelo Febo; Madhavan Nair
Journal:  Sci Rep       Date:  2018-08-28       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.